CVS director trades 30,437 shares at $93.78 avg

CVS Health director Fernando Aguirre reported returning shares of common stock to the company.

Rhea-AI Filing Summary

CVS Health director Fernando Aguirre reported returning shares of common stock to the company. On May 20, he disposed of 30,437 shares of CVS common stock to the issuer at a weighted average price of $93.775 per share. On May 21, he disposed of an additional 1,563 shares to the issuer at a weighted average price of $93.501 per share, with individual trades that day ranging between $93.50 and $94.01 per share. After these transactions, he directly held 10,513 CVS shares, and no derivative securities were reported in this filing.

Insider Trade Summary

Disposition: 32,000 shares

Disposition 2 txns

Insider AGUIRRE FERNANDO

Role Director

Type	Security	Shares	Price	Value
Disposition	Common Stock	1,563	$93.501	$146K
Disposition	Common Stock	30,437	$93.775	$2.85M

Holdings After Transaction: Common Stock — 10,513 shares (Direct)

Footnotes (2)

1. F1. Represents weighted average purchase price for this group of purchases, which occurred on the same day. Multiple purchases were conducted, with prices ranging between $93.50 and $94.01 per share.
2. F2. Represents weighted average purchase price of 93.775 per share.

Key Figures

Shares disposed May 20: 30,437 shares Weighted average price May 20: $93.775 per share Shares disposed May 21: 1,563 shares +3 more

6 metrics

Shares disposed May 20 30,437 shares Common Stock, disposition to issuer on May 20

Weighted average price May 20 $93.775 per share Common Stock disposition to issuer

Shares disposed May 21 1,563 shares Common Stock, disposition to issuer on May 21

Weighted average price May 21 $93.501 per share Common Stock disposition to issuer; multiple trades that day

Post-transaction holdings 10,513 shares Direct CVS common stock held after reported transactions

Total shares disposed 32,000 shares Sum of May 20 and May 21 issuer dispositions

Key Terms

Disposition to issuer, weighted average purchase price, Common Stock, Form 4

4 terms

Disposition to issuer financial

"transaction_code_description": "Disposition to issuer""

weighted average purchase price financial

"Represents weighted average purchase price for this group of purchases"

The weighted average purchase price is the average cost per share you paid across multiple buys, calculated so larger purchases count more than smaller ones. Imagine buying apples at different prices: the overall price you effectively paid depends on how many apples you bought at each price. Investors use it to measure true cost basis, calculate gains or losses, decide when to sell, and manage taxes and portfolio performance.

Common Stock financial

"security_title": "Common Stock""

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

Form 4 regulatory

"INSIDER FILING DATA (Form 4)"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did CVS (CVS) director Fernando Aguirre report?

Fernando Aguirre reported returning common shares to CVS as issuer dispositions. He disposed of 30,437 shares on May 20 and 1,563 shares on May 21, both classified as "Disposition to issuer" rather than open‑market sales or purchases.

How many CVS (CVS) shares did Fernando Aguirre dispose of and at what prices?

Aguirre disposed of 30,437 CVS common shares on May 20 at a weighted average price of $93.775, and 1,563 shares on May 21 at a weighted average price of $93.501, with trades that day ranging between $93.50 and $94.01 per share.

How many CVS (CVS) shares does Fernando Aguirre hold after these Form 4 transactions?

After the reported issuer dispositions, Aguirre directly holds 10,513 CVS common shares. This post‑transaction holding figure comes from the Form 4 totals, which show his remaining direct ownership following the May 20 and May 21 common stock disposals.

Were Fernando Aguirre’s CVS (CVS) transactions open‑market sales or something else?

The filing classifies both transactions with code D as "Disposition to issuer." This indicates shares were returned to CVS rather than sold on the open market, which is different from a standard open‑market sale coded as "S" on Form 4.

Does the CVS (CVS) Form 4 for Fernando Aguirre show any derivative securities activity?

The Form 4 reports no derivative security transactions for Aguirre. The derivative summary is empty, and all reported activity involves non‑derivative CVS common stock classified as issuer dispositions on May 20 and May 21.

How does the CVS (CVS) Form 4 describe pricing for Fernando Aguirre’s May 21 transaction?

The May 21 transaction footnote states a weighted average price of $93.501 per share, with multiple trades executed that day between $93.50 and $94.01 per share, providing detail on the pricing range for the grouped transaction.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/22/2026 - 05:39 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

AGUIRRE FERNANDO

(Last) (First) (Middle)

ONE CVS DRIVE

(Street)

WOONSOCKET RHODE ISLAND 02895

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
CVS HEALTH Corp [ CVS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/20/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	05/20/2026		D(1)		30,437	D	$93.775	12,076	D
Common Stock	05/21/2026		D(2)		1,563	D	$93.501	10,513	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents weighted average purchase price for this group of purchases, which occurred on the same day. Multiple purchases were conducted, with prices ranging between $93.50 and $94.01 per share.

2. Represents weighted average purchase price of 93.775 per share.

	/s/ Fernando Aguirre	05/22/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)